How do you like your knees in the morning?: The Tipline for 30 August 2018

A former chief economist at the Antitrust Division yesterday testified on behalf of the Federal Trade Commission in an effort to undo the Ottobock/Freedom Innovations merger. Meanwhile, a federal appellate court reversed the dismissal of claims brought by a seller of cardiac monitoring devices against Blue Cross Blue Shield Association and several associated health insurance companies. We also have updates on Cigna’s proposed acquisition of Express Scripts, as well as Makan Delrahim and Joe Simons testifying on Capitol Hill later this autumn.

Get unlimited access to all Global Competition Review content